Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1956 1
1963 4
1964 4
1965 4
1966 5
1967 2
1968 2
1969 3
1970 4
1971 4
1972 3
1973 2
1974 1
1975 5
1976 3
1977 4
1978 3
1979 3
1980 7
1981 4
1982 7
1983 2
1984 5
1985 5
1986 8
1987 6
1988 4
1989 10
1990 9
1991 9
1992 8
1993 6
1994 9
1995 14
1996 5
1997 6
1998 5
1999 7
2000 16
2001 15
2002 12
2003 6
2004 12
2005 10
2006 7
2007 11
2008 11
2009 9
2010 13
2011 15
2012 16
2013 11
2014 19
2015 20
2016 25
2017 36
2018 30
2019 30
2020 47
2021 44
2022 54
2023 25
2024 38
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

681 results

Results by year

Filters applied: . Clear all
Page 1
Secondary Antibiotic Prophylaxis for Latent Rheumatic Heart Disease.
Beaton A, Okello E, Rwebembera J, Grobler A, Engelman D, Alepere J, Canales L, Carapetis J, DeWyer A, Lwabi P, Mirabel M, Mocumbi AO, Murali M, Nakitto M, Ndagire E, Nunes MCP, Omara IO, Sarnacki R, Scheel A, Wilson N, Zimmerman M, Zühlke L, Karthikeyan G, Sable CA, Steer AC. Beaton A, et al. Among authors: zimmerman m. N Engl J Med. 2022 Jan 20;386(3):230-240. doi: 10.1056/NEJMoa2102074. Epub 2021 Nov 13. N Engl J Med. 2022. PMID: 34767321 Clinical Trial.
Nine-year prospective efficacy and safety of brain-responsive neurostimulation for focal epilepsy.
Nair DR, Laxer KD, Weber PB, Murro AM, Park YD, Barkley GL, Smith BJ, Gwinn RP, Doherty MJ, Noe KH, Zimmerman RS, Bergey GK, Anderson WS, Heck C, Liu CY, Lee RW, Sadler T, Duckrow RB, Hirsch LJ, Wharen RE Jr, Tatum W, Srinivasan S, McKhann GM, Agostini MA, Alexopoulos AV, Jobst BC, Roberts DW, Salanova V, Witt TC, Cash SS, Cole AJ, Worrell GA, Lundstrom BN, Edwards JC, Halford JJ, Spencer DC, Ernst L, Skidmore CT, Sperling MR, Miller I, Geller EB, Berg MJ, Fessler AJ, Rutecki P, Goldman AM, Mizrahi EM, Gross RE, Shields DC, Schwartz TH, Labar DR, Fountain NB, Elias WJ, Olejniczak PW, Villemarette-Pittman NR, Eisenschenk S, Roper SN, Boggs JG, Courtney TA, Sun FT, Seale CG, Miller KL, Skarpaas TL, Morrell MJ; RNS System LTT Study. Nair DR, et al. Among authors: zimmerman rs. Neurology. 2020 Sep 1;95(9):e1244-e1256. doi: 10.1212/WNL.0000000000010154. Epub 2020 Jul 20. Neurology. 2020. PMID: 32690786 Free PMC article.
Effect of Low-Dose Supplementation of Arginine Vasopressin on Need for Blood Product Transfusions in Patients With Trauma and Hemorrhagic Shock: A Randomized Clinical Trial.
Sims CA, Holena D, Kim P, Pascual J, Smith B, Martin N, Seamon M, Shiroff A, Raza S, Kaplan L, Grill E, Zimmerman N, Mason C, Abella B, Reilly P. Sims CA, et al. Among authors: zimmerman n. JAMA Surg. 2019 Nov 1;154(11):994-1003. doi: 10.1001/jamasurg.2019.2884. JAMA Surg. 2019. PMID: 31461138 Free PMC article. Clinical Trial.
At 48 hours, patients who received AVP required significantly less blood products (median, 1.4 [IQR, 0.5-2.6] vs 2.9 [IQR, 1.1-4.8] L; P = .01) but did not differ in requirements for crystalloids (median, 9.9 [IQR, 7.9-13.0] vs 11.0 [8.9-15.0] L; P = .22) or vasopre …
At 48 hours, patients who received AVP required significantly less blood products (median, 1.4 [IQR, 0.5-2.6] vs 2.9 [IQR, 1.1-4.8] L
CAR-engineered lymphocyte persistence is governed by a FAS ligand/FAS auto-regulatory circuit.
Yi F, Cohen T, Zimmerman N, Dündar F, Zumbo P, Eltilib R, Brophy EJ, Arkin H, Feucht J, Gormally MV, Hackett CS, Kropp KN, Etxeberria I, Chandran SS, Park JH, Hsu KC, Sadelain M, Betel D, Klebanoff CA. Yi F, et al. Among authors: zimmerman n. bioRxiv [Preprint]. 2024 Mar 1:2024.02.26.582108. doi: 10.1101/2024.02.26.582108. bioRxiv. 2024. PMID: 38464085 Free PMC article. Preprint.
Chimeric antigen receptor (CAR)-engineered T and NK cells can cause durable remission of B-cell malignancies; however, limited persistence restrains the full potential of these therapies in many patients. The FAS ligand (FAS-L)/FAS pathway governs naturally-occurring lymph …
Chimeric antigen receptor (CAR)-engineered T and NK cells can cause durable remission of B-cell malignancies; however, limited persistence r …
Generation of precision preclinical cancer models using regulated in vivo base editing.
Katti A, Vega-Pérez A, Foronda M, Zimmerman J, Zafra MP, Granowsky E, Goswami S, Gardner EE, Diaz BJ, Simon JM, Wuest A, Luan W, Fernandez MTC, Kadina AP, Walker JA 2nd, Holden K, Lowe SW, Sánchez Rivera FJ, Dow LE. Katti A, et al. Among authors: zimmerman j. Nat Biotechnol. 2024 Mar;42(3):437-447. doi: 10.1038/s41587-023-01900-x. Epub 2023 Aug 10. Nat Biotechnol. 2024. PMID: 37563300 Free PMC article.
Prevalence and Clinical Outcomes of Respiratory Syncytial Virus vs Influenza in Adults Hospitalized With Acute Respiratory Illness From a Prospective Multicenter Study.
Begley KM, Monto AS, Lamerato LE, Malani AN, Lauring AS, Talbot HK, Gaglani M, McNeal T, Silveira FP, Zimmerman RK, Middleton DB, Ghamande S, Murthy K, Kim L, Ferdinands JM, Patel MM, Martin ET. Begley KM, et al. Among authors: zimmerman rk. Clin Infect Dis. 2023 Jun 8;76(11):1980-1988. doi: 10.1093/cid/ciad031. Clin Infect Dis. 2023. PMID: 36694363 Free PMC article.
Picenadol.
Zimmerman DM, Smits SE, Hynes MD, Cantrell BE, Leander JD, Mendelsohn LG, Nickander R. Zimmerman DM, et al. Drug Alcohol Depend. 1985 Feb;14(3-4):381-401. doi: 10.1016/0376-8716(85)90069-9. Drug Alcohol Depend. 1985. PMID: 2986931
Structurally, picenadol is a 4-phenylpiperidine derivative and a racemic mixture whose mixed agonist-antagonist properties are a consequence of the d-isomer being a potent opiate agonist, whereas the l-isomer is an opioid antagonist. In the mouse writhing and rat tail heat …
Structurally, picenadol is a 4-phenylpiperidine derivative and a racemic mixture whose mixed agonist-antagonist properties are a consequence …
Sports-Related Concussions and the Pediatric Patient.
Zimmerman SD, Vernau BT, Meehan WP 3rd, Master CL. Zimmerman SD, et al. Clin Sports Med. 2021 Jan;40(1):147-158. doi: 10.1016/j.csm.2020.08.010. Clin Sports Med. 2021. PMID: 33187605 Review.
Multimodality Imaging in Arrhythmogenic Right Ventricular Cardiomyopathy.
Malik N, Mukherjee M, Wu KC, Zimmerman SL, Zhan J, Calkins H, James CA, Gilotra NA, Sheikh FH, Tandri H, Kutty S, Hays AG. Malik N, et al. Among authors: zimmerman sl. Circ Cardiovasc Imaging. 2022 Feb;15(2):e013725. doi: 10.1161/CIRCIMAGING.121.013725. Epub 2022 Feb 11. Circ Cardiovasc Imaging. 2022. PMID: 35147040 Review.
Pegaspargase-induced pancreatitis.
Alvarez OA, Zimmerman G. Alvarez OA, et al. Among authors: zimmerman g. Med Pediatr Oncol. 2000 Mar;34(3):200-5. doi: 10.1002/(sici)1096-911x(200003)34:3<200::aid-mpo7>3.0.co;2-t. Med Pediatr Oncol. 2000. PMID: 10696127
All had prior therapy with native L-asparaginase. These children developed symptoms consisting of abdominal pain, nausea, vomiting, and decreased appetite within a median of 15 days from the onset of pegaspargase administration. ...In contrast, only one out of 52 (1.9%) AL …
All had prior therapy with native L-asparaginase. These children developed symptoms consisting of abdominal pain, nausea, vomiting, a …
681 results